John E. Bowen
Molecular Biology · 2020–2022
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 135 citations into it
Whom John E. Bowen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from John E. Bowen's perspective
Ordered by how strongly the researchers John E. Bowen trusts endorse each paper. Same corpus, a different order for every researcher.
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus (PLoS Pathogens)
- Data, disease and diplomacy: GISAID's innovative contribution to global health (Global Challenges)
- Mapping the Antigenic and Genetic Evolution of Influenza Virus
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- A Bayesian View on Cryo-EM Structure Determination (IEEE International Symposium on Biomedical Imaging)
- Deep mutational scanning: a new style of protein science
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays (bioRxiv)
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (Science)
Their papers
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding (2020) — 1,185 citations
- Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding (2020) — 968 citations
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity (2022) — 904 citations
- SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies (2021) — 524 citations
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) — 1,119 citations
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (2020) — 317 citations
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms (2020) — 509 citations
- Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation (2020) — 161 citations